Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (291-300 of 1,126) with videos related to

Pageof 113
Sort By:
Cancer Medicine|December 5, 2024
Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre INTERVAL-GAP4 TrialLisa Umlauff, Stacey A Kenfield, Robert U Newton, et al.
The Canadian Journal of Urology|December 3, 2008
Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinicDaniel Taussky, Aihua Liu, Michal Abrahamowicz, et al.
World Journal of Urology|May 28, 2020
PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitionsMarina Deuker, L Franziska Stolzenbach, Angela Pecoraro, et al.
Targeted Oncology|May 21, 2025
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA MutationFred Saad, Andrew J Armstrong, Neal Shore, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2019
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate CancerEric Lévesque, Patrick Caron, Louis Lacombe, et al.
Urology|July 24, 2019
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient SampleSophie Knipper, Elio Mazzone, Francesco A Mistretta, et al.
European Urology|January 23, 2022
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate CancerVanessa Di Lalla, Michael J Kucharczyk, Alexander W Wyatt, et al.
The Oncologist|March 25, 2024
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate CancerWilliam J Phillips, Fred Saad, Jennifer Leigh, et al.
European Urology|September 21, 2024
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEdoardo Francini, Neeraj Agarwal, Elena Castro, et al.
Pageof 113

Showing results (291-300 of 1,126) with videos related to

Sort By:
Pageof 113
Cancer Medicine|December 5, 2024
Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre INTERVAL-GAP4 TrialLisa Umlauff, Stacey A Kenfield, Robert U Newton, et al.
The Canadian Journal of Urology|December 3, 2008
Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinicDaniel Taussky, Aihua Liu, Michal Abrahamowicz, et al.
World Journal of Urology|May 28, 2020
PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitionsMarina Deuker, L Franziska Stolzenbach, Angela Pecoraro, et al.
Targeted Oncology|May 21, 2025
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA MutationFred Saad, Andrew J Armstrong, Neal Shore, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2019
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate CancerEric Lévesque, Patrick Caron, Louis Lacombe, et al.
Urology|July 24, 2019
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient SampleSophie Knipper, Elio Mazzone, Francesco A Mistretta, et al.
European Urology|January 23, 2022
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate CancerVanessa Di Lalla, Michael J Kucharczyk, Alexander W Wyatt, et al.
The Oncologist|March 25, 2024
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate CancerWilliam J Phillips, Fred Saad, Jennifer Leigh, et al.
European Urology|September 21, 2024
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEdoardo Francini, Neeraj Agarwal, Elena Castro, et al.
Pageof 113